Aleksandr Kogan and Alexander Nix; Analysis To Aid Public Comment, 37645-37646 [2019-16372]

Download as PDF Federal Register / Vol. 84, No. 148 / Thursday, August 1, 2019 / Notices assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than August 26, 2019. A. Federal Reserve Bank of Minneapolis (Mark A. Rauzi, Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Lake Shore III Corporation, Glenwood City, Wisconsin; to acquire 100 percent of the voting shares of First American Bank, National Association, Hudson, Wisconsin. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. First State Bancshares, Inc., New London, Wisconsin; to merge with Pioneer Bancorp, Inc., and thereby indirectly acquire Pioneer Bank, both of Auburndale, Wisconsin. Board of Governors of the Federal Reserve System, July 26, 2019. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2019–16352 Filed 7–31–19; 8:45 am] BILLING CODE P FEDERAL TRADE COMMISSION jspears on DSK3GMQ082PROD with NOTICES [File Nos. 182 3106 and 182 3107] Aleksandr Kogan and Alexander Nix; Analysis To Aid Public Comment Federal Trade Commission. Proposed consent agreements; Request for comment. AGENCY: ACTION: The consent agreements in these matters settle alleged violations of SUMMARY: VerDate Sep<11>2014 19:14 Jul 31, 2019 Jkt 247001 federal law prohibiting unfair or deceptive acts or practices. The attached Analysis to Aid Public Comment describes both the allegations in the complaint and the terms of the consent orders—embodied in the consent agreements—that would settle these allegations. DATES: Comments must be received on or before September 3, 2019. ADDRESSES: Interested parties may file comments online or on paper, by following the instructions in the Request for Comment part of the SUPPLEMENTARY INFORMATION section below. Write: ‘‘Aleksandr Kogan and Alexander Nix; File Nos. 182 3106 and 182 3107’’ on your comment, and file your comment online at https:// www.regulations.gov by following the instructions on the web-based form. If you prefer to file your comment on paper, mail your comment to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC–5610 (Annex D), Washington, DC 20580, or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 5610 (Annex D), Washington, DC 20024. FOR FURTHER INFORMATION CONTACT: Linda Holleran Kopp (202–326–2267), Bureau of Consumer Protection, Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC 20580. SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule 2.34, 16 CFR 2.34, notice is hereby given that the above-captioned consent agreement containing a consent order to cease and desist, having been filed with and accepted, subject to final approval, by the Commission, has been placed on the public record for a period of thirty (30) days. The following Analysis to Aid Public Comment describes the terms of the consent agreement and the allegations in the complaint. An electronic copy of the full text of the consent agreement package can be obtained from the FTC Home Page (for July 24, 2019), on the World Wide Web, at https:// www.ftc.gov/news-events/commissionactions. You can file a comment online or on paper. For the Commission to consider your comment, we must receive it on or before September 3, 2019. Write ‘‘Aleksandr Kogan and Alexander Nix; File Nos. 182 3106 and 182 3107’’ on your comment. Your comment— including your name and your state— will be placed on the public record of PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 37645 this proceeding, including, to the extent practicable, on the https:// www.regulations.gov website. Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online through the https:// www.regulations.gov website. If you prefer to file your comment on paper, write ‘‘Aleksandr Kogan and Alexander Nix; File Nos. 182 3106 and 182 3107’’ on your comment and on the envelope, and mail your comment to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC–5610 (Annex D), Washington, DC 20580; or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 5610 (Annex D), Washington, DC 20024. If possible, submit your paper comment to the Commission by courier or overnight service. Because your comment will be placed on the publicly accessible website at https://www.regulations.gov, you are solely responsible for making sure that your comment does not include any sensitive or confidential information. In particular, your comment should not include any sensitive personal information, such as your or anyone else’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including in particular competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. Comments containing material for which confidential treatment is requested must be filed in paper form, must be clearly labeled ‘‘Confidential,’’ and must comply with FTC Rule 4.9(c). In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the E:\FR\FM\01AUN1.SGM 01AUN1 37646 Federal Register / Vol. 84, No. 148 / Thursday, August 1, 2019 / Notices jspears on DSK3GMQ082PROD with NOTICES comment to be withheld from the public record. See FTC Rule 4.9(c). Your comment will be kept confidential only if the General Counsel grants your request in accordance with the law and the public interest. Once your comment has been posted on the public FTC website—as legally required by FTC Rule 4.9(b)—we cannot redact or remove your comment from the FTC website, unless you submit a confidentiality request that meets the requirements for such treatment under FTC Rule 4.9(c), and the General Counsel grants that request. Visit the FTC website at http:// www.ftc.gov to read this Notice and the news release describing it. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding, as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before September 3, 2019. For information on the Commission’s privacy policy, including routine uses permitted by the Privacy Act, see https://www.ftc.gov/site-information/ privacy-policy. Analysis of Proposed Consent Orders To Aid Public Comment The Federal Trade Commission (‘‘Commission’’) has accepted, subject to final approval, two agreements containing consent orders from Aleksandr Kogan and Alexander Nix, individuals. The proposed consent orders have been placed on the public record for thirty (30) days for receipt of comments by interested persons. Comments received during this period will become part of the public record. After thirty (30) days, the Commission will again review the agreements and the comments received, and will decide whether it should withdraw from the agreements and take appropriate action or make final the agreements’ proposed orders. Aleksandr Kogan, until September 2018, was a Senior Research Associate and Lecturer at the Department of Psychology at the University of Cambridge in the United Kingdom. Kogan was also the developer of a Facebook application called the GSRApp, sometimes publicly referred to as the ‘‘thisisyourdigitallife’’ app. Alexander Nix, until April 2018, was the Chief Executive Officer of Cambridge Analytica LLC and the head of SCL Elections Ltd. The Commission’s proposed complaint alleges that Kogan, together with the data analytics company, Cambridge Analytica, LLC, and its Chief VerDate Sep<11>2014 19:14 Jul 31, 2019 Jkt 247001 Executive Officer, Alexander Nix, used the GSRApp to harvest certain Facebook user profile data from approximately 250,000–270,000 Facebook users who directly interacted with the app (‘‘App Users’’), as well as 50–65 million of the ‘‘friends’’ in those users’ Facebook social network. The proposed complaint alleges that Respondents obtained the App Users’ consent to collect their Facebook profile data through false and deceptive means. The Commission’s proposed complaint alleges a violation of Section 5(a) of the Federal Trade Commission Act, specifically that Respondents’ representation to App Users that it would not ‘‘download [their] name or any other identifiable information’’ was deceptive because the GSRApp, in fact, collected identifiable information from these users, including their Facebook User ID.1 The proposed consent orders contain injunctive provisions addressing Kogan’s and Nix’s alleged unlawful conduct. Part I of the proposed consent orders prohibits Kogan and Nix from making false or deceptive statements regarding the extent to which they protect the privacy and confidentiality of Covered Information as defined in the proposed consent orders, including: A. The extent to which they collect, use, share, or sell any Covered Information; and B. The purposes for which they collect, use, share, or sell any Covered Information. Part II of the proposed consent orders relates to the deletion and destruction of Covered Information collected through the GSRApp, and any information or work product, including any algorithms, derived from such Covered Information, and requires Kogan and Nix to: A. Provide a written statement, sworn under penalty of perjury, with the name, address, and phone number for each person with whom they shared any 1 The Commission also issued an administrative complaint against Cambridge Analytica alleging a similar deception count as well as two additional counts related to its participation in Privacy Shield, a framework that allows companies to transfer personal data lawfully from the European Union to the United States. The complaint alleges that representations on Cambridge Analytica’s website that Cambridge Analytica participated in Privacy Shield after May 2018 were deceptive because the company did not take the steps necessary to renew Cambridge Analytica’s certification when it expired in May 2018. The complaint also alleges that representations on Cambridge Analytica’s website that Cambridge Analytica adheres to Privacy Shield’s principles were deceptive because Cambridge Analytica failed to comply with Privacy Shield’s requirement to affirm to the Commerce Department that the company would continue to apply the principles to personal information that it received during the time it participated in the program. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Covered Information collected from consumers through GSRApp, and any information or work product that originated, in whole or in part, from this Covered Information; and B. Delete or destroy all Covered Information collected from consumers though the GSRApp, and any information or work product, including any algorithms or equations, that originated, in whole or in part, from this Covered Information, which destruction must generally occur within ten (10) days from the effective date of the proposed orders. Kogan and Nix must then provide a statement, sworn under penalty of perjury, confirming that the data has been destroyed or deleted. Parts III through VII of the proposed consent orders are reporting and compliance provisions, which include recordkeeping requirements and provisions requiring Respondents to provide information or documents necessary for the Commission to monitor compliance. The proposed consent orders will be in effect for twenty (20) years. The purpose of this analysis is to aid public comment on the proposed orders. It is not intended to constitute an official interpretation of the proposed complaint or proposed orders, or to modify in any way the proposed orders’ terms. By direction of the Commission. April J. Tabor, Acting Secretary. [FR Doc. 2019–16372 Filed 7–31–19; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2019–D–2330] Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers; Draft Guidance for Industry; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ‘‘Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers.’’ This draft guidance represents FDA’s current thinking on the management and conduct of pathology peer review performed during good laboratory practice (GLP)- SUMMARY: E:\FR\FM\01AUN1.SGM 01AUN1

Agencies

[Federal Register Volume 84, Number 148 (Thursday, August 1, 2019)]
[Notices]
[Pages 37645-37646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16372]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION

[File Nos. 182 3106 and 182 3107]


Aleksandr Kogan and Alexander Nix; Analysis To Aid Public Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreements; Request for comment.

-----------------------------------------------------------------------

SUMMARY: The consent agreements in these matters settle alleged 
violations of federal law prohibiting unfair or deceptive acts or 
practices. The attached Analysis to Aid Public Comment describes both 
the allegations in the complaint and the terms of the consent orders--
embodied in the consent agreements--that would settle these 
allegations.

DATES: Comments must be received on or before September 3, 2019.

ADDRESSES: Interested parties may file comments online or on paper, by 
following the instructions in the Request for Comment part of the 
SUPPLEMENTARY INFORMATION section below. Write: ``Aleksandr Kogan and 
Alexander Nix; File Nos. 182 3106 and 182 3107'' on your comment, and 
file your comment online at https://www.regulations.gov by following 
the instructions on the web-based form. If you prefer to file your 
comment on paper, mail your comment to the following address: Federal 
Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, 
Suite CC-5610 (Annex D), Washington, DC 20580, or deliver your comment 
to the following address: Federal Trade Commission, Office of the 
Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 
5610 (Annex D), Washington, DC 20024.

FOR FURTHER INFORMATION CONTACT: Linda Holleran Kopp (202-326-2267), 
Bureau of Consumer Protection, Federal Trade Commission, 600 
Pennsylvania Avenue NW, Washington, DC 20580.

SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal 
Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule 2.34, 16 CFR 2.34, 
notice is hereby given that the above-captioned consent agreement 
containing a consent order to cease and desist, having been filed with 
and accepted, subject to final approval, by the Commission, has been 
placed on the public record for a period of thirty (30) days. The 
following Analysis to Aid Public Comment describes the terms of the 
consent agreement and the allegations in the complaint. An electronic 
copy of the full text of the consent agreement package can be obtained 
from the FTC Home Page (for July 24, 2019), on the World Wide Web, at 
https://www.ftc.gov/news-events/commission-actions.
    You can file a comment online or on paper. For the Commission to 
consider your comment, we must receive it on or before September 3, 
2019. Write ``Aleksandr Kogan and Alexander Nix; File Nos. 182 3106 and 
182 3107'' on your comment. Your comment--including your name and your 
state--will be placed on the public record of this proceeding, 
including, to the extent practicable, on the https://www.regulations.gov website.
    Postal mail addressed to the Commission is subject to delay due to 
heightened security screening. As a result, we encourage you to submit 
your comments online through the https://www.regulations.gov website.
    If you prefer to file your comment on paper, write ``Aleksandr 
Kogan and Alexander Nix; File Nos. 182 3106 and 182 3107'' on your 
comment and on the envelope, and mail your comment to the following 
address: Federal Trade Commission, Office of the Secretary, 600 
Pennsylvania Avenue NW, Suite CC-5610 (Annex D), Washington, DC 20580; 
or deliver your comment to the following address: Federal Trade 
Commission, Office of the Secretary, Constitution Center, 400 7th 
Street SW, 5th Floor, Suite 5610 (Annex D), Washington, DC 20024. If 
possible, submit your paper comment to the Commission by courier or 
overnight service.
    Because your comment will be placed on the publicly accessible 
website at https://www.regulations.gov, you are solely responsible for 
making sure that your comment does not include any sensitive or 
confidential information. In particular, your comment should not 
include any sensitive personal information, such as your or anyone 
else's Social Security number; date of birth; driver's license number 
or other state identification number, or foreign country equivalent; 
passport number; financial account number; or credit or debit card 
number. You are also solely responsible for making sure that your 
comment does not include any sensitive health information, such as 
medical records or other individually identifiable health information. 
In addition, your comment should not include any ``trade secret or any 
commercial or financial information which . . . is privileged or 
confidential''--as provided by Section 6(f) of the FTC Act, 15 U.S.C. 
46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)--including in 
particular competitively sensitive information such as costs, sales 
statistics, inventories, formulas, patterns, devices, manufacturing 
processes, or customer names.
    Comments containing material for which confidential treatment is 
requested must be filed in paper form, must be clearly labeled 
``Confidential,'' and must comply with FTC Rule 4.9(c). In particular, 
the written request for confidential treatment that accompanies the 
comment must include the factual and legal basis for the request, and 
must identify the specific portions of the

[[Page 37646]]

comment to be withheld from the public record. See FTC Rule 4.9(c). 
Your comment will be kept confidential only if the General Counsel 
grants your request in accordance with the law and the public interest. 
Once your comment has been posted on the public FTC website--as legally 
required by FTC Rule 4.9(b)--we cannot redact or remove your comment 
from the FTC website, unless you submit a confidentiality request that 
meets the requirements for such treatment under FTC Rule 4.9(c), and 
the General Counsel grants that request.
    Visit the FTC website at http://www.ftc.gov to read this Notice and 
the news release describing it. The FTC Act and other laws that the 
Commission administers permit the collection of public comments to 
consider and use in this proceeding, as appropriate. The Commission 
will consider all timely and responsive public comments that it 
receives on or before September 3, 2019. For information on the 
Commission's privacy policy, including routine uses permitted by the 
Privacy Act, see https://www.ftc.gov/site-information/privacy-policy.

Analysis of Proposed Consent Orders To Aid Public Comment

    The Federal Trade Commission (``Commission'') has accepted, subject 
to final approval, two agreements containing consent orders from 
Aleksandr Kogan and Alexander Nix, individuals.
    The proposed consent orders have been placed on the public record 
for thirty (30) days for receipt of comments by interested persons. 
Comments received during this period will become part of the public 
record. After thirty (30) days, the Commission will again review the 
agreements and the comments received, and will decide whether it should 
withdraw from the agreements and take appropriate action or make final 
the agreements' proposed orders.
    Aleksandr Kogan, until September 2018, was a Senior Research 
Associate and Lecturer at the Department of Psychology at the 
University of Cambridge in the United Kingdom. Kogan was also the 
developer of a Facebook application called the GSRApp, sometimes 
publicly referred to as the ``thisisyourdigitallife'' app.
    Alexander Nix, until April 2018, was the Chief Executive Officer of 
Cambridge Analytica LLC and the head of SCL Elections Ltd.
    The Commission's proposed complaint alleges that Kogan, together 
with the data analytics company, Cambridge Analytica, LLC, and its 
Chief Executive Officer, Alexander Nix, used the GSRApp to harvest 
certain Facebook user profile data from approximately 250,000-270,000 
Facebook users who directly interacted with the app (``App Users''), as 
well as 50-65 million of the ``friends'' in those users' Facebook 
social network. The proposed complaint alleges that Respondents 
obtained the App Users' consent to collect their Facebook profile data 
through false and deceptive means.
    The Commission's proposed complaint alleges a violation of Section 
5(a) of the Federal Trade Commission Act, specifically that 
Respondents' representation to App Users that it would not ``download 
[their] name or any other identifiable information'' was deceptive 
because the GSRApp, in fact, collected identifiable information from 
these users, including their Facebook User ID.\1\
---------------------------------------------------------------------------

    \1\ The Commission also issued an administrative complaint 
against Cambridge Analytica alleging a similar deception count as 
well as two additional counts related to its participation in 
Privacy Shield, a framework that allows companies to transfer 
personal data lawfully from the European Union to the United States. 
The complaint alleges that representations on Cambridge Analytica's 
website that Cambridge Analytica participated in Privacy Shield 
after May 2018 were deceptive because the company did not take the 
steps necessary to renew Cambridge Analytica's certification when it 
expired in May 2018. The complaint also alleges that representations 
on Cambridge Analytica's website that Cambridge Analytica adheres to 
Privacy Shield's principles were deceptive because Cambridge 
Analytica failed to comply with Privacy Shield's requirement to 
affirm to the Commerce Department that the company would continue to 
apply the principles to personal information that it received during 
the time it participated in the program.
---------------------------------------------------------------------------

    The proposed consent orders contain injunctive provisions 
addressing Kogan's and Nix's alleged unlawful conduct. Part I of the 
proposed consent orders prohibits Kogan and Nix from making false or 
deceptive statements regarding the extent to which they protect the 
privacy and confidentiality of Covered Information as defined in the 
proposed consent orders, including:
    A. The extent to which they collect, use, share, or sell any 
Covered Information; and
    B. The purposes for which they collect, use, share, or sell any 
Covered Information.
    Part II of the proposed consent orders relates to the deletion and 
destruction of Covered Information collected through the GSRApp, and 
any information or work product, including any algorithms, derived from 
such Covered Information, and requires Kogan and Nix to:
    A. Provide a written statement, sworn under penalty of perjury, 
with the name, address, and phone number for each person with whom they 
shared any Covered Information collected from consumers through GSRApp, 
and any information or work product that originated, in whole or in 
part, from this Covered Information; and
    B. Delete or destroy all Covered Information collected from 
consumers though the GSRApp, and any information or work product, 
including any algorithms or equations, that originated, in whole or in 
part, from this Covered Information, which destruction must generally 
occur within ten (10) days from the effective date of the proposed 
orders. Kogan and Nix must then provide a statement, sworn under 
penalty of perjury, confirming that the data has been destroyed or 
deleted.
    Parts III through VII of the proposed consent orders are reporting 
and compliance provisions, which include recordkeeping requirements and 
provisions requiring Respondents to provide information or documents 
necessary for the Commission to monitor compliance. The proposed 
consent orders will be in effect for twenty (20) years.
    The purpose of this analysis is to aid public comment on the 
proposed orders. It is not intended to constitute an official 
interpretation of the proposed complaint or proposed orders, or to 
modify in any way the proposed orders' terms.

    By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2019-16372 Filed 7-31-19; 8:45 am]
BILLING CODE 6750-01-P